# Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients

> **NCT04512950** · PHASE4 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 43626 (actual)

## Conditions studied

- Fluid Therapy

## Interventions

- **DRUG:** Ringer's lactate
- **DRUG:** 0.9% saline

## Key facts

- **NCT ID:** NCT04512950
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-15
- **Primary completion:** 2020-06-13
- **Final completion:** 2020-06-13
- **Target enrollment:** 43626 (ACTUAL)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04512950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04512950, "Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04512950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
